Tonix Pharmaceuticals Holding (STU:TPM0) Beginning Cash Position : €23.78 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Tonix Pharmaceuticals Holding Beginning Cash Position?

Tonix Pharmaceuticals Holding's Beginning Cash Position for the quarter that ended in Mar. 2024 was €23.78 Mil.

Tonix Pharmaceuticals Holding's quarterly Beginning Cash Position declined from Sep. 2023 (€24.23 Mil) to Dec. 2023 (€7.26 Mil) but then increased from Dec. 2023 (€7.26 Mil) to Mar. 2024 (€23.78 Mil).

Tonix Pharmaceuticals Holding's annual Beginning Cash Position increased from Dec. 2021 (€68.42 Mil) to Dec. 2022 (€168.88 Mil) but then declined from Dec. 2022 (€168.88 Mil) to Dec. 2023 (€110.47 Mil).

Tonix Pharmaceuticals Holding Beginning Cash Position Historical Data

The historical data trend for Tonix Pharmaceuticals Holding's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonix Pharmaceuticals Holding Beginning Cash Position Chart

Tonix Pharmaceuticals Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

22.62

9.33

68.42

168.88

110.47

Tonix Pharmaceuticals Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															112.52	66.66	24.23	7.26	23.78

Tonix Pharmaceuticals Holding Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Tonix Pharmaceuticals Holding Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Tonix Pharmaceuticals Holding's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Tonix Pharmaceuticals Holding (STU:TPM0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tonix Pharmaceuticals Holding Corp (STU:TPM0) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

TNXP:USA

Address

26 Main Street, Suite 101, Chatham, NJ, USA, 07928

Website

https://www.tonixpharma.com

Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.

Tonix Pharmaceuticals Holding (STU:TPM0) Headlines

No Headlines